Par Pharmaceutical Companies, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Par Pharmaceutical Companies, Inc. - overview

Established

1978

Location

Woodcliff Lake, NJ, US

Primary Industry

Pharmaceuticals

About

Founded in 1978 and based in NJ, US, Par Pharmaceutical Companies, Inc. is a specialty pharmaceutical company. Through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures and markets high-barrier-to-entry generic drugs and proprietary pharmaceuticals.


Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development

Website

www.parpharm.com

Verticals

Manufacturing

Company Stage

Acquired

Total Amount Raised

Subscriber access only

Par Pharmaceutical Companies, Inc. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Trade SaleCompletedPar Pharmaceutical Companies, Inc.-
Add-on, Trade SaleCompletedJHP Group Holdings, Inc.-
RecapitalisationCompletedPar Pharmaceutical Companies, Inc.-
Public to PrivateCompletedPar Pharmaceutical Companies, Inc.-

Displaying 1 - 4 of 4

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.